Citations (14)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Vasilios G Athyros, Niki Katsiki & Asterios Karagiannis. (2013) Comment on: Novel therapeutic targets for non-alcoholic fatty liver disease. Expert Opinion on Therapeutic Targets 17:7, pages 861-862.
Read now
Read now
Vasilios G Athyros, Niki Katsiki, Asterios Karagiannis & Dimitri P Mikhailidis. (2013) Statins and nonalcoholic fatty liver disease: a bright future?. Expert Opinion on Investigational Drugs 22:9, pages 1089-1093.
Read now
Read now
Articles from other publishers (12)
Nong Li, Huiwen Tan, Aixia Xie, Cheng Li, Xuan Fu, Weiting Xang, Amina Kirim & Xuefang Huang. (2022) Value of the triglyceride glucose index combined with body mass index in identifying non-alcoholic fatty liver disease in patients with type 2 diabetes. BMC Endocrine Disorders 22:1.
Crossref
Crossref
Chongyan Zhao, Qingsong Qu, Fang Yang, Zhixun Li, Pengshuo Yang, Lu Han & Xinyuan Shi. (2021) Monascus ruber fermented Panax ginseng ameliorates lipid metabolism disorders and modulate gut microbiota in rats fed a high-fat diet. Journal of Ethnopharmacology 278, pages 114300.
Crossref
Crossref
Deanna M Salter, Wei Wei, Pragati P Nahar, Emily Marques & Angela L Slitt. (2021) Perfluorooctanesulfonic Acid (PFOS) Thwarts the Beneficial Effects of Calorie Restriction and Metformin. Toxicological Sciences 182:1, pages 82-95.
Crossref
Crossref
Komal Thapa, Ajmer Singh Grewal, Neha Kanojia, Lata Rani, Neelam Sharma & Sukhbir Singh. (2021) Alcoholic and Non-Alcoholic Liver Diseases: Promising Molecular Drug Targets and their Clinical Development. Current Drug Discovery Technologies 18:3, pages 333-353.
Crossref
Crossref
Ashley R. DeGroat, Christina K. Fleming, Samantha M. Dunlay, Kendra L. Hagood, Jonathan P. Moorman & Jonathan M. Peterson. (2018) The sex specific effect of alcohol consumption on circulating levels of CTRP3. PLOS ONE 13:11, pages e0207011.
Crossref
Crossref
Akiko Eguchi, Xavier De Mollerat Du Jeu, Casey D. Johnson, Andronikou Nektaria & Ariel E. Feldstein. (2016) Liver Bid suppression for treatment of fibrosis associated with non-alcoholic steatohepatitis. Journal of Hepatology 64:3, pages 699-707.
Crossref
Crossref
Vajiheh Rangboo, Mostafa Noroozi, Roza Zavoshy, Seyed Amirmansoor Rezadoost & Asghar Mohammadpoorasl. (2016) The Effect of Artichoke Leaf Extract on Alanine Aminotransferase and Aspartate Aminotransferase in the Patients with Nonalcoholic Steatohepatitis. International Journal of Hepatology 2016, pages 1-6.
Crossref
Crossref
Michal Ganz, Terence N Bukong, Timea Csak, Banishree Saha, Jin-Kyu Park, Aditya Ambade, Karen Kodys & Gyongyi Szabo. (2015) Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat–cholesterol–sugar diet model in mice. Journal of Translational Medicine 13:1.
Crossref
Crossref
Vasilios G Athyros, Konstantinos Tziomalos, Niki Katsiki, Michael Doumas, Asterios Karagiannis & Dimitri P Mikhailidis. (2015) Cardiovascular risk across the histological spectrum and the clinical manifestations of non-alcoholic fatty liver disease: An update. World Journal of Gastroenterology 21:22, pages 6820-6834.
Crossref
Crossref
Huiping Zhou & Phillip B. Hylemon. (2014) Bile acids are nutrient signaling hormones. Steroids 86, pages 62-68.
Crossref
Crossref
Yesim Ozturk & Ozlem Bekem Soylu. (2014) Fatty liver in childhood. World Journal of Hepatology 6:1, pages 33.
Crossref
Crossref
Xiao-Yan Wang, Zhi-Ling Yu, Si-Yuan Pan, Yi Zhang, Nan Sun, Pei-Li Zhu, Zhan-Hong Jia, Shu-Feng Zhou & Kam-Ming Ko. (2014) Supplementation with the Extract of Schisandrae Fructus Pulp, Seed, or Their Combination Influences the Metabolism of Lipids and Glucose in Mice Fed with Normal and Hypercholesterolemic Diet. Evidence-Based Complementary and Alternative Medicine 2014, pages 1-11.
Crossref
Crossref